# Prompts to LLM:

You are assisting a team of expert clinical pharmacists, drug interaction pharmacology researchers, and persons who edit drug interaction knowledge compendia. You help synthesize evidence about possible interactions between prescription drugs and natural products (botanical or herbal) based on the most recent and relevant information. Ground your response in factual data from your pre-train set or any context provided by the user, explicitly referencing or quoting authoritative sources when possible. In your response, think carefully and be specific about the source of the information used in each answer, and avoid citing sources if the information is not a direct citation from that source. Always explain your reasoning. Make it explicit when you base your reasoning on pharmacological inference rather than a direct citation from a textual source. Focus on factuality since you must evaluate your answer in the end. Structure your response using the following nine-item template: 

Item 1: A list of each potential mechanism, showing each step in your thinking and providing evidence to support each step involved.  

Item 2: A description of the natural product mentioned in the query. Please include a list of known names to refer to the product and note how it is prepared or consumed.  

Item 3: A summary of the pharmacokinetic properties of the natural product mentioned in the query. If available, include values for the Area Under the Curve change at therapeutic concentrations linked to a pharmacodynamic effect, information on common administration routes, and the average amount of bioactive compounds in the products. 

Item 4: A brief description of the drug mentioned in the query. Include a list of known names used to refer to the drug. 

Item 5: A summary of the pharmacokinetic properties of the drug mentioned in the query. If available, include values for the Area Under the Curve change at therapeutic concentrations linked to a pharmacodynamic effect, information on common administration routes, and standardized dosage of the drug's active ingredient.

Item 6: A summarized description of the adverse event mentioned in the query. List known potential causes and if the mentioned natural product or drug is associated with the adverse event. Include all available details regarding the average onset time of the adverse event. Include all available information regarding the likelihood of overlapping effects of the adverse event. Include all available details regarding the potential additive nature of the side effects involved in the adverse event. 

Item 7: A list and description of any mention of clinical importance for the interaction, including the frequency of the mentions. 

Item 8: A list of other drugs with similar pharmacodynamic and pharmacokinetic properties to the drug in the query that could interact with the natural product mentioned. 

Item 9: A list of other natural products with similar pharmacodynamic and pharmacokinetic properties to the natural product in the query that could interact with the drug mentioned.

Finally, classify how accurate your synthesis was. Rate your confidence in your answers on a scale of 1-5, 1 being very low and 5 being very high.



### Context ###


Include relevant items from the following information in your synthesis:
The Natural Product curcumin molecularly interacts with the Enzyme or Transporter ATP-dependent translocase ABCB1 (human). The Drug tacrolimus (anhydrous) transports the Enzyme or Transporter ATP-dependent translocase ABCB1 (human). And the Drug tacrolimus (anhydrous) is causally correlated with the Adverse Event acute kidney failure. Natural Product Ontology Identifier: http://napdi.org/napdi_srs_imports:curcuma_longa Natural Product or Constituent Ontology Identifier: http://purl.obolibrary.org/obo/CHEBI_3962 Process Ontology Identifier: http://purl.obolibrary.org/obo/RO_0002436 Enzyme or Transporter Ontology Identifier: http://purl.obolibrary.org/obo/PR_P08183 Process or Pathway Ontology Identifier: http://purl.obolibrary.org/obo/RO_0002020 Drug Ontology Identifier: http://purl.obolibrary.org/obo/CHEBI_61049 Causal Relation Ontology Identifier: http://purl.obolibrary.org/obo/RO_0002610 Adverse Event Ontology Identifier: http://purl.obolibrary.org/obo/MONDO_0002492

-----

The Natural Product curcumin directly negatively regulates activity of the Enzyme or Transporter cytochrome P450 3A4 (human). The Drug tacrolimus (anhydrous) is substrate of the Enzyme or Transporter cytochrome P450 3A4 (human). And the Drug tacrolimus (anhydrous) is causally correlated with the Adverse Event peripheral neuropathy. Natural Product Ontology Identifier: http://napdi.org/napdi_srs_imports:curcuma_longa Natural Product or Constituent Ontology Identifier: http://purl.obolibrary.org/obo/CHEBI_3962 Process Ontology Identifier: http://purl.obolibrary.org/obo/RO_0002449 Enzyme or Transporter Ontology Identifier: http://purl.obolibrary.org/obo/PR_P08684 Process or Pathway Ontology Identifier: http://purl.obolibrary.org/obo/DIDEO_00000041 Drug Ontology Identifier: http://purl.obolibrary.org/obo/CHEBI_61049 Causal Relation Ontology Identifier: http://purl.obolibrary.org/obo/RO_0002610 Adverse Event Ontology Identifier: http://purl.obolibrary.org/obo/MONDO_0005244

-----

The Natural Product 1,8-cineole interacts with the Enzyme or Transporter cytochrome P450 3A4 (human). The Drug tacrolimus (anhydrous) molecularly interacts with the Enzyme or Transporter cytochrome P450 3A4 (human). And the Drug tacrolimus (anhydrous) is causally correlated with the Adverse Event acute kidney failure. Natural Product Ontology Identifier: http://napdi.org/napdi_srs_imports:curcuma_longa Natural Product or Constituent Ontology Identifier: http://purl.obolibrary.org/obo/CHEBI_27961 Process Ontology Identifier: http://purl.obolibrary.org/obo/RO_0002434 Enzyme or Transporter Ontology Identifier: http://purl.obolibrary.org/obo/PR_P08684 Process or Pathway Ontology Identifier: http://purl.obolibrary.org/obo/RO_0002436 Drug Ontology Identifier: http://purl.obolibrary.org/obo/CHEBI_61049 Causal Relation Ontology Identifier: http://purl.obolibrary.org/obo/RO_0002610 Adverse Event Ontology Identifier: http://purl.obolibrary.org/obo/MONDO_0002492

### Query ###

What are the potential mechanisms that cause an interaction between Turmeric products and Tacrolimus that may cause Nephrotoxicity?

-------

# Response from LLM:

### Item 1: Potential Mechanisms

Based on the provided information, the potential mechanisms that cause an interaction between Turmeric products (containing Curcumin) and Tacrolimus that may cause Nephrotoxicity are:

1. **Inhibition of ATP-dependent translocase ABCB1 (human) by Curcumin**: Curcumin can inhibit the activity of ATP-dependent translocase ABCB1, which is also transported by Tacrolimus. This could potentially lead to increased concentrations of Tacrolimus in the body, increasing the risk of Nephrotoxicity. 
2. **Inhibition of cytochrome P450 3A4 (human) by Curcumin**: Curcumin can inhibit the activity of cytochrome P450 3A4, which is involved in the metabolism of Tacrolimus. This could potentially lead to increased concentrations of Tacrolimus in the body, increasing the risk of Nephrotoxicity.

### Item 2: Description of the Natural Product - Turmeric

Turmeric (Curcuma longa) is a plant-based spice commonly consumed in the form of curcuminoids, which are extracted from the rhizome of the plant. Turmeric products, including supplements and extracts, contain curcumin as the primary active compound.

### Item 3: Pharmacokinetic Properties of Turmeric

Curcumin has poor bioavailability due to rapid metabolism by cytochrome P450 3A4 and phase II conjugation enzymes. The average amount of bioactive compounds in Turmeric products can vary widely depending on the extraction method and concentration.

* Area Under the Curve (AUC) change: Not available
* Administration routes: Oral, topical
* Average amount of bioactive compounds: 1-5% curcuminoids (curcumin, demethoxycurcumin, bisdemethoxycurcumin)

### Item 4: Description of the Drug - Tacrolimus

Tacrolimus (anhydrous) is an immunosuppressive drug used to prevent organ rejection in transplant patients. It is a substrate of cytochrome P450 3A4 and is transported by ATP-dependent translocase ABCB1.

### Item 5: Pharmacokinetic Properties of Tacrolimus

Tacrolimus has a narrow therapeutic window and is metabolized by cytochrome P450 3A4.

* Area Under the Curve (AUC) change: Not available
* Administration routes: Oral, intravenous
* Standardized dosage: 0.1-0.2 mg/kg/day (oral)

### Item 6: Description of the Adverse Event - Nephrotoxicity

Nephrotoxicity is a well-documented adverse effect of Tacrolimus, characterized by kidney damage and impaired renal function. The likelihood of overlapping effects of nephrotoxicity with Turmeric products is unknown. However, the potential for additive effects of nephrotoxicity cannot be ruled out, as Turmeric products may increase the risk of nephrotoxicity by inhibiting the activity of cytochrome P450 3A4 and ATP-dependent translocase ABCB1.

### Item 7: Clinical Importance of the Interaction

The interaction between Turmeric products and Tacrolimus may have clinical importance, as it may lead to increased concentrations of Tacrolimus and increased risk of Nephrotoxicity. However, the frequency of this interaction is unknown and requires further study.

### Item 8: Other Drugs with Similar Pharmacodynamic and Pharmacokinetic Properties

Other drugs with similar pharmacodynamic and pharmacokinetic properties to Tacrolimus that could interact with Turmeric products include:

* Cyclosporine (an immunosuppressive drug metabolized by cytochrome P450 3A4)
* Sirolimus (an immunosuppressive drug metabolized by cytochrome P450 3A4)

### Item 9: Other Natural Products with Similar Pharmacodynamic and Pharmacokinetic Properties

Other natural products with similar pharmacodynamic and pharmacokinetic properties to Turmeric products that could interact with Tacrolimus include:

* 1,8-Cineole (an essential oil extracted from Eucalyptus and other plants, which interacts with cytochrome P450 3A4)

### Accuracy of Synthesis

Confidence rating: 4/5

Note: The potential mechanisms of interaction between Turmeric products and Tacrolimus are based on the provided information, but the clinical importance and frequency of this interaction require further study.